139 related articles for article (PubMed ID: 16254034)
41. Distribution of glucocorticoid receptors and 11β-hydroxysteroid dehydrogenase isoforms in the human inner ear.
Kumagami H; Terakado M; Takahashi H
Otol Neurotol; 2013 Jan; 34(1):151-7. PubMed ID: 22996157
[TBL] [Abstract][Full Text] [Related]
42. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth.
McNeil CJ; Nwagwu MO; Finch AM; Page KR; Thain A; McArdle HJ; Ashworth CJ
Reproduction; 2007 Mar; 133(3):653-61. PubMed ID: 17379659
[TBL] [Abstract][Full Text] [Related]
43. Characterization of a novel oral glucocorticoid system and its possible role in disease.
Cirillo N; Hassona Y; Pignatelli M; Gasparoto TH; Morgan DJ; Prime SS
J Dent Res; 2012 Jan; 91(1):97-103. PubMed ID: 22067259
[TBL] [Abstract][Full Text] [Related]
44. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
Livingstone DE; Walker BR
J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
[TBL] [Abstract][Full Text] [Related]
45. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
Ricketts ML; Stewart PM
Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
Thompson A; Han VK; Yang K
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):367-75. PubMed ID: 15145446
[TBL] [Abstract][Full Text] [Related]
47. Localization of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in the male reproductive tract.
Waddell BJ; Hisheh S; Krozowski ZS; Burton PJ
Endocrinology; 2003 Jul; 144(7):3101-6. PubMed ID: 12810566
[TBL] [Abstract][Full Text] [Related]
48. 11β-Hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor γ.
Beck KR; Inderbinen SG; Kanagaratnam S; Kratschmar DV; Jetten AM; Yamaguchi H; Odermatt A
J Lipid Res; 2019 Sep; 60(9):1535-1546. PubMed ID: 31273032
[TBL] [Abstract][Full Text] [Related]
49. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
[TBL] [Abstract][Full Text] [Related]
50. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
[TBL] [Abstract][Full Text] [Related]
51. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910
[TBL] [Abstract][Full Text] [Related]
52. [Expression of 11β-hydroxysteroid dehydrogenase type 2 in lymphoblastic cells and its relationship with glucocorticoid sensitivity].
Tao Y; Shi JM; Zhang YX; Gao L; Zhan FH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):109-13. PubMed ID: 21362233
[TBL] [Abstract][Full Text] [Related]
53. Modulation of 11 beta-hydroxysteroid dehydrogenase type 2 activity in Ishikawa cells is associated with changes in cellular proliferation.
Koyama K; Krozowski Z
Mol Cell Endocrinol; 2001 Oct; 183(1-2):165-70. PubMed ID: 11604236
[TBL] [Abstract][Full Text] [Related]
54. Targeting 11β-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease.
Hardy RS; Seibel MJ; Cooper MS
Curr Opin Pharmacol; 2013 Jun; 13(3):440-4. PubMed ID: 23540586
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical analysis of 11-beta-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical Cushing's disease due to pituitary macroadenoma.
Ebisawa T; Tojo K; Tajima N; Kamio M; Oki Y; Ono K; Sasano H
Endocr Pathol; 2008; 19(4):252-60. PubMed ID: 19048413
[TBL] [Abstract][Full Text] [Related]
56. 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics.
Sandeep TC; Yau JL; MacLullich AM; Noble J; Deary IJ; Walker BR; Seckl JR
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6734-9. PubMed ID: 15071189
[TBL] [Abstract][Full Text] [Related]
57. Cortisol metabolism in hypertension.
Hammer F; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):337-53. PubMed ID: 16980198
[TBL] [Abstract][Full Text] [Related]
58. Inflammatory mediators down-regulate 11beta-hydroxysteroid dehydrogenase type 2 in a human lung epithelial cell line BEAS-2B and the rat lung.
Suzuki S; Tsubochi H; Ishibashi H; Matsuda Y; Suzuki T; Krozowski ZS; Sasano H; Kondo T
Tohoku J Exp Med; 2005 Dec; 207(4):293-301. PubMed ID: 16272800
[TBL] [Abstract][Full Text] [Related]
59. 11β-Hydroxysteroid dehydrogenase type 1 activity in short small-for-GA children and in response to GH therapy.
Zuckerman-Levin N; Tsivlin L; Knopf C; Flor O; Shen-Orr Z; Levin M; Hochberg Z
Pediatr Res; 2011 Aug; 70(2):208-12. PubMed ID: 21544007
[TBL] [Abstract][Full Text] [Related]
60. Persistent hypokalemia after successful adrenalectomy in a patient with Cushing's syndrome due to ectopic ACTH secretion: possible role of 11beta-hydroxysteroid dehydrogenase inhibition.
Arteaga E; Fardella C; Campusano C; Cárdenas I; Martinez P
J Endocrinol Invest; 1999 Dec; 22(11):857-9. PubMed ID: 10710274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
